The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis

This study aimed to assess the effects of dydrogesterone on sexual function in women with endometriosis using Female Function Sexual Index (FSFI).

Sexual dysfunction is an important outcome for patients with endometriosis. In this study, we compare the fsfi (female sexual function index) questions and the scores before and after dydrogesterone treatment in patients with endometriosis. We aim to measure the effect of dydrogesterone in patients with endometriosis.

Inclusion Criteria:

• no history of malignancies,
• normal findings at gynecological examinations and transvaginal ultrasonography
• normal uterine size, normal cervical smear results,
• patients not use any contraception methods in the last 6 months

Exclusion Criteria:

• with a history of systemic and/or psychiatric diseases,
• gynecological pathologies (myoma uteri, endometriosis, uterine anomalies, existing genital infections)
• pelvic organ prolapse
• pelvic surgeries